146 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
will have the option to engage (at its own expense, except as otherwise provided below) an independent internationally-recognized certified public … the batch which is in dispute will promptly be submitted for testing and evaluation to an independent Third Party (including a testing laboratory
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
year ended December 31, 2022, have been audited by Haskell & White LLP, independent registered public accounting firm, as set forth in their report … by Haskell & White LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein
8-K
EX-4.1
FENC
Fennec Pharmaceuticals Inc
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
(as the case may be), then then the Holder may, with the consent of the Company not to be unreasonably or untimely withheld, select an independent
8-K
37fjj
12 Jun 23
Submission of Matters to a Vote of Security Holders
6:24pm
424B3
53yxj3 xpv6
15 Dec 22
Prospectus supplement
5:12pm
8-K
EX-4.1
yrtk0c53ihu08hhkg
26 Sep 22
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment
5:03pm
8-K
EX-4.1
22p 5zta6
22 Aug 22
Fennec Pharmaceuticals Closes First $5 Million Investment
9:00am
8-K
EX-10.1
7mvyajyle6y9h
1 Aug 22
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
4:15pm